000 | 01073 a2200277 4500 | ||
---|---|---|---|
005 | 20250513080601.0 | ||
264 | 0 | _c19930408 | |
008 | 199304s 0 0 eng d | ||
022 | _a1058-4838 | ||
024 | 7 |
_a10.1093/clind/16.2.340 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAdal, K A | |
245 | 0 | 0 |
_aDetermination of the pathogenicity of Entamoeba histolytica. _h[electronic resource] |
260 |
_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _cFeb 1993 |
||
300 |
_a340 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCarrier State _xdrug therapy |
650 | 0 | 4 |
_aEntamoeba histolytica _xpathogenicity |
650 | 0 | 4 |
_aEntamoebiasis _xdrug therapy |
650 | 0 | 4 | _aHumans |
700 | 1 | _aKress, K | |
700 | 1 | _aPetri, W A | |
773 | 0 |
_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 16 _gno. 2 _gp. 340 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/clind/16.2.340 _zAvailable from publisher's website |
999 |
_c8442597 _d8442597 |